A Potent MAPK13-14 Inhibitor Prevents Airway Inflammation and Mucus Production

By
Jamie Kang
-
0
161
Scientists reported the next generation and selection of a potent MAPK13-14 inhibitor that more effectively down-regulated type-2 cytokine-stimulated mucus production in air-liquid interface and organoid cultures of human airway epithelial cells.
[American Journal Of Physiology-Lung Cellular And Molecular Physiology]
Abstract